$-0.59 EPS Expected for Cellectis SA (ADR) (CLLS); Last Week National General Holdings (NGHC) Coverage

September 2, 2017 - By Stephen Andrade

Analysts expect Cellectis SA (ADR) (NASDAQ:CLLS) to report $-0.59 EPS on September, 14.They anticipate $0.39 EPS change or 195.00% from last quarter’s $-0.2 EPS. After having $-0.56 EPS previously, Cellectis SA (ADR)’s analysts see 5.36% EPS growth. The stock increased 11.89% or $3.42 on September 1, reaching $32.18. About 608,287 shares traded or 428.46% up from the average. Cellectis SA (ADR) (NASDAQ:CLLS) has declined 17.09% since September 2, 2016 and is downtrending. It has underperformed by 33.79% the S&P500.

Among 2 analysts covering National General Holdings Corp (NASDAQ:NGHC), 1 have Buy rating, 0 Sell and 1 Hold. Therefore 50% are positive. National General Holdings Corp had 9 analyst reports since August 7, 2015 according to SRatingsIntel. As per Thursday, August 27, the company rating was downgraded by Zacks. On Tuesday, January 26 the stock rating was upgraded by Morgan Stanley to “Overweight”. Morgan Stanley maintained National General Holdings Corp (NASDAQ:NGHC) on Thursday, August 10 with “Equal-Weight” rating. Keefe Bruyette & Woods maintained National General Holdings Corp (NASDAQ:NGHC) rating on Tuesday, June 20. Keefe Bruyette & Woods has “Buy” rating and $2700 target. The rating was downgraded by Morgan Stanley on Friday, November 18 to “Equal-Weight”. William Blair maintained National General Holdings Corp (NASDAQ:NGHC) on Tuesday, August 25 with “Outperform” rating. The stock of National General Holdings Corp (NASDAQ:NGHC) earned “Buy” rating by Keefe Bruyette & Woods on Monday, August 28. The rating was maintained by Keefe Bruyette & Woods on Sunday, July 23 with “Buy”. The rating was downgraded by Zacks to “Buy” on Friday, August 7. See National General Holdings Corp (NASDAQ:NGHC) latest ratings:

28/08/2017 Broker: Keefe Bruyette & Woods Rating: Buy New Target: $27.0 Maintain
10/08/2017 Broker: Morgan Stanley Rating: Equal-Weight Old Target: $25 New Target: $23 Maintain
23/07/2017 Broker: Keefe Bruyette & Woods Rating: Buy New Target: $27.0000 Maintain
20/06/2017 Broker: Keefe Bruyette & Woods Rating: Buy New Target: $27.0000 Maintain

Among 5 analysts covering Cellectis (NASDAQ:CLLS), 5 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Cellectis had 7 analyst reports since April 5, 2016 according to SRatingsIntel. Ladenburg Thalmann initiated Cellectis SA (ADR) (NASDAQ:CLLS) on Tuesday, April 5 with “Buy” rating. The firm has “Buy” rating given on Tuesday, June 6 by Jefferies. On Wednesday, August 16 the stock rating was maintained by Oppenheimer with “Buy”. The rating was maintained by Oppenheimer with “Buy” on Friday, June 2. The company was maintained on Thursday, August 24 by Jefferies. The rating was initiated by Wells Fargo with “Outperform” on Tuesday, February 28.

Cellectis SA is a France-based company active in the field of genome engineering and genomic surgery. The company has market cap of $1.21 billion. The Firm specializes in the research, development and commercialization of rational genome engineering technologies. It currently has negative earnings. It has developed an expertise in combining meganucleases with engineered targeting Deoxyribonucleic Acid matrices into Meganuclease Recombination Systems (MRS), used for gene excision, correction or replacement.

Since March 27, 2017, it had 5 insider purchases, and 3 sales for $121.62 million activity. On Tuesday, March 28 the insider Karfunkel Robert bought $572,000. On Friday, June 9 the insider Rendall Peter A. sold $720,020. 5,000 National General Holdings Corp (NASDAQ:NGHC) shares with value of $108,850 were bought by MARSHALECK JOHN. Another trade for 31,600 shares valued at $724,550 was made by Karfunkel Barry on Wednesday, March 29. $123.08 million worth of National General Holdings Corp (NASDAQ:NGHC) was sold by AMTRUST INTERNATIONAL INSURANCE LTD. Newgarden Thomas sold $948,810 worth of stock or 40,100 shares.

The stock decreased 1.28% or $0.22 on September 1, reaching $16.95. About 328,425 shares traded or 8.11% up from the average. National General Holdings Corp (NASDAQ:NGHC) has risen 0.61% since September 2, 2016 and is uptrending. It has underperformed by 16.09% the S&P500.

Investors sentiment increased to 1.48 in Q4 2016. Its up 0.36, from 1.12 in 2016Q3. It increased, as 7 investors sold National General Holdings Corp shares while 53 reduced holdings. 14 funds opened positions while 41 raised stakes. 42.57 million shares or 3.52% less from 44.13 million shares in 2016Q3 were reported. Allianz Asset Ag holds 0.05% of its portfolio in National General Holdings Corp (NASDAQ:NGHC) for 2.04M shares. 930,730 were accumulated by Schroder Investment Mngmt Grp. Park West Asset Management Limited Liability reported 2.73 million shares. Ftb Advisors holds 0% of its portfolio in National General Holdings Corp (NASDAQ:NGHC) for 801 shares. Hodges Capital Mngmt Inc owns 457,940 shares. Symphony Asset Mngmt Lc owns 0.1% invested in National General Holdings Corp (NASDAQ:NGHC) for 39,537 shares. California Pub Employees Retirement System holds 0.01% of its portfolio in National General Holdings Corp (NASDAQ:NGHC) for 260,700 shares. Delphi Mgmt Inc Ma holds 1.14% or 78,314 shares. Blackrock has 0% invested in National General Holdings Corp (NASDAQ:NGHC) for 15,477 shares. Barclays Public Ltd stated it has 2,217 shares. Credit Agricole S A has 0.03% invested in National General Holdings Corp (NASDAQ:NGHC) for 390,000 shares. Nationwide Fund Advisors invested 0.01% of its portfolio in National General Holdings Corp (NASDAQ:NGHC). Moreover, Bancorporation Of America Corporation De has 0% invested in National General Holdings Corp (NASDAQ:NGHC) for 229,968 shares. State Board Of Administration Of Florida Retirement Sys reported 17,230 shares stake. Denali Ltd Liability Co reported 27 shares.

National General Holdings Corp. is a specialty personal lines insurance holding company. The company has market cap of $1.78 billion. Through its subsidiaries, the Company provides a range of insurance products, including personal and commercial automobile, homeowners, umbrella, recreational vehicle, supplemental health, lender-placed and other niche products. It has a 23.15 P/E ratio. It operates through two divisions: Property and Casualty and Accident and Health (A&H).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Twitter Auto Publish Powered By : XYZScripts.com